Get the Stockscreener App
75.52
0.17%
-0.125
Hologic Inc stock is traded at $75.52, with a volume of 517.90K.
It is down -0.17% in the last 24 hours and up +0.22% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$75.64
Open:
$75.51
24h Volume:
517.90K
Relative Volume:
0.19
Market Cap:
$16.86B
Revenue:
$4.13B
Net Income/Loss:
$543.90M
P/E Ratio:
31.33
EPS:
2.41
Net Cash Flow:
$957.20M
1W Performance:
+0.62%
1M Performance:
+0.22%
6M Performance:
+13.73%
1Y Performance:
+22.01%
1-Day Range:
$75.44
$75.60
1-Week Range:
$75.03
$75.64
52-Week Range:
$51.90
$75.75
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.52 | 16.89B | 4.13B | 543.90M | 957.20M | 2.41 |
ISRG
Intuitive Surgical Inc
|
472.41 | 169.79B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.75 | 44.44B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.28 | 36.14B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
41.98 | 34.48B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.94 | 33.21B | 5.40B | 1.49B | 1.78B | 10.12 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-12-26 | Downgrade | Argus | Buy → Hold |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-21-25 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Hologic upgraded at Evercore ISI on growth turnaround - MSN
Investors heavily search Hologic, Inc. (HOLX): Here is what you need to know - MSN
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know - Yahoo Finance
U.S. Exosomes Market to Skyrocket During 2026-2033, Reaching $716.8 MillionAnalysis of Lucrative Business Opportunities and Key Players; Danaher, Thermo Fisher Scientific, Hologic, Fujifilm, Lonza and More - Yahoo Finance
Investors Are Actively Looking Into Hologic, Inc. (HOLX): What You Should Be Aware Of - Bitget
Hologic's Women's Health Index Flags Alarming Gaps in STI Screening - Yahoo Finance Singapore
Hologic, Inc. $HOLX Shares Sold by JPMorgan Chase & Co. - MarketBeat
Should You Keep or Offload HOLX Shares as It Approaches the Conclusion of Its Public Phase? - Bitget
Is Hologic Stock Outperforming the Dow? - Yahoo Finance
Should You Hold or Sell HOLX Stock as It Nears the End of Public Phase? - Yahoo! Finance Canada
Mammography Devices Market Poised for Robust Growth at 8.25% - openPR.com
Mammography Devices Market Poised for Robust Growth at 8.25% CAGR Through 2034: DelveInsight | Hologic, GE Healthcare, and Siemens Healthineers - Barchart.com
Aug PreEarnings: How is Hologic Inc managing supply chain issuesGold Moves & Expert Curated Trade Setups - baoquankhu1.vn
1,5 Milliarden Frauen verpassen wichtige Vorsorgeuntersuchungen – trotz weltweit steigender Screening-Raten - Eagle-Tribune
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates - Hologic
Brevan Howard Capital Management LP Increases Position in Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. $HOLX Shares Sold by Alliancebernstein L.P. - MarketBeat
Hologic, Inc. (NASDAQ:HOLX) Given Average Rating of "Hold" by Brokerages - MarketBeat
Sectra acquiring Oxipit | RadNet's $300M in 2026 acquisitions | Hologic clears hurdle in $18B sale to PE | More - Radiology Business
Technical Reactions to HOLX Trends in Macro Strategies - Stock Traders Daily
Hologic, Inc. $HOLX Shares Purchased by Gotham Asset Management LLC - MarketBeat
Cinctive Capital Management LP Buys 23,119 Shares of Hologic, Inc. $HOLX - MarketBeat
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests - MSN
Earnest Partners LLC Purchases 26,877 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. $HOLX Shares Sold by Integral Health Asset Management LLC - MarketBeat
Why Hologic Just Hit Your Health And Money Feeds At Once - AD HOC NEWS
Korea Investment CORP Has $2.66 Million Stake in Hologic, Inc. $HOLX - MarketBeat
Mackenzie Financial Corp Sells 141,733 Shares of Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Sexually Transmitted Disease Testing Market size to exceed - openPR.com
Natixis Advisors LLC Acquires 82,894 Shares of Hologic, Inc. $HOLX - MarketBeat
What Drives Hologic's GYN Surgical Strength in a Competitive Market? - The Globe and Mail
Dimensional Fund Advisors LP Has $155.75 Million Position in Hologic, Inc. $HOLX - MarketBeat
Molecular Diagnostics Market Outlook: Set to Grow at 10%+ CAGR Through 2031 as Precision Medicine and Genetic Testing Advance, Says Mordor Intelligence - GlobeNewswire Inc.
What Factors Contribute to Hologic's GYN Surgical Success Amidst Market Competition? - Bitget
Hologic, Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators - Markets Mojo
BioZorb Lawsuit and Settlement Information: March 2026 - AboutLawsuits.com
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - sharewise.com
Hologic, Inc. $HOLX Shares Bought by Crossmark Global Holdings Inc. - MarketBeat
Here’s What You Should Understand Besides Why Hologic, Inc. (HOLX) is Gaining Attention - Bitget
Here’s What You Should Understand Besides the Fact That Hologic, Inc. (HOLX) is Gaining Attention - Bitget
Munich Reinsurance Co Stock Corp in Munich Purchases Shares of 61,962 Hologic, Inc. $HOLX - MarketBeat
Hologic, Inc. Hits New 52-Week High at $75.75, Reflecting Strong Performance - Markets Mojo
Hologic's Diagnostics Strength in Focus: Is More Upside Ahead? - Yahoo Finance
Aug Levels: Does Hologic Inc have a sustainable dividendJuly 2025 Drop Watch & Detailed Earnings Play Alerts - baoquankhu1.vn
Allegations of Toxic Leadership and Corruption in Hologic’s HR Department Raise Concerns About Workplace Culture - geneonline.com
Hologic Shares Edge Up 0.11% as Trading Volume Surges 149.8% to Rank 295th - Bitget
Hologic stock hits 52-week high at 75.49 USD By Investing.com - Investing.com Nigeria
Hologic, Inc. Hits New 52-Week High of $75.69, Marking Strong Growth - Markets Mojo
Trading the Move, Not the Narrative: (HOLX) Edition - Stock Traders Daily
GW&K Investment Management LLC Grows Stock Holdings in Hologic, Inc. $HOLX - MarketBeat
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
1.41%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):